Oxford Nanopore Technologies plc (ONTTF)

Market Cap	1.46B +7.0%
Revenue (ttm)	301.35M +22.2%
Net Income	-195.42M
EPS	-0.20
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,225
Average Volume	20,096
Open	1.530
Previous Close	1.650
Day's Range	1.530 - 1.530
52-Week Range	1.240 - 3.340
Beta	0.83
RSI	42.13
Earnings Date	Mar 2, 2026

About ONTTF

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its cu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 1,335
• Stock Exchange: OTCMKTS
• Ticker Symbol: ONTTF

Financial Performance

In 2025, ONTTF's revenue was 223.90 million, an increase of 22.22% compared to the previous year's 183.19 million. Losses were -145.20 million, -0.68% less than in 2024.

Financial numbers in GBP